The US Food and Drug Administration is warning health care providers about potential biocompatibility and design issues with NuVasive’s specialized orthopedics Precice devices, which are made from steel and titanium. The agency says adverse events including pain, and changes in the surrounding bone and soft tissue have been record by patients implanted with the Precice Stryde, the steel version of the product.
The devices are intended for use by patients 18 and older to lengthen or compress their limbs or transport segments...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?